Executive Summary
The pharmacy project in the medical and health sector in Spain targets a promising market opportunity. With an investment of €250,000, it achieves a net present value of €-63,875, an internal rate of return of -0%, and a payback period of — years.
| Indicator | Value |
|---|---|
| Initial Investment | €٢٥٠٬٠٠٠ |
| First-Year Revenue | €٤٥٠٬٠٠٠ |
| Annual Growth (CAGR) | ٥٪ |
| Net Margin (Y1) | -١٪ |
| Return on Investment (Avg) | -٠٪ annually |
| Net Present Value (NPV) | €-٦٣٬٨٧٥ |
| Internal Rate of Return (IRR) | -٠٪ |
| Profitability Index (PI) | ١ |
| Payback Period | — |
| Break-even Year | — |
| Expected NPV (Probability-Weighted) | €-٦٢٬٢٧٨ |
Assumptions and Basis
The figures in this study are based on project data, the nature of the medical and health sector in Spain, and local market indicators, according to the following assumptions:
| Assumption | Value |
|---|---|
| Initial Capital | €٢٥٠٬٠٠٠ |
| First-Year Revenue | €٤٥٠٬٠٠٠ |
| Annual Growth | ٥٪ |
| Cost of Goods Sold (COGS) | ٦٥٪ of revenue |
| Operating Expenses | ٢٥٪ of revenue |
| Tax/Zakat | ١٥٪ |
| Discount Rate (WACC) | ١٠٪ |
| Study Horizon | ٥ years |
Basis of Assumptions: These figures are based on the average revenues of pharmacies in Spain, the typical cost structure for the sector, and tax rates for new projects.
Project Description and Opportunity
The pharmacy project in Spain aims to meet the increasing demand for medicines and healthcare products, supported by a robust healthcare system and an aging population [5, 6]. Pharmacies in Spain are not merely points of sale; they are key community centers for accessing health information, medications, and personal care products [2, 7]. The business model will focus on providing a wide range of prescription drugs and over-the-counter (OTC) products, in addition to offering specialized pharmaceutical services such as health advice and medication management [7, 32]. The target customer is the local community, including families, seniors, and individuals seeking reliable and accessible healthcare.
Market and Demand Study
The pharmacy market in Spain is large and growing, with a size of 30.7 billion euros in 2026 [3]. The market has grown at a compound annual growth rate (CAGR) of 2.3% between 2021 and 2026 [3]. Key factors driving market growth include an aging population, increased healthcare spending, and growing demand for innovative treatments [5, 6]. Additionally, pharmaceutical networks in Spain highly trust pharmacists, which influences product visibility and recommendations [28]. The market is highly regulated, where pharmacies must be owned and managed by licensed pharmacists and are subject to strict licensing requirements and location regulations [2, 7].
Market Sizing (TAM / SAM / SOM)
The Total Addressable Market (TAM) was sized based on the total volume of the pharmacy market in Spain for 2026, estimated at €30.7 billion [3]. The Serviceable Available Market (SAM) represents the segment of community pharmacies that the project can reach, considering regulatory constraints on location and density [2]. The Serviceable Obtainable Market (SOM) was estimated as a small percentage of the available market achievable during the first years of operation, based on targeted operational capacity and customer acquisition rate.
| Level | Annual Size | Description |
|---|---|---|
| TAM — Total Addressable Market | €30700.0 million | Total addressable demand |
| SAM — Serviceable Available Market | €1500.0 million | The segment your model reaches |
| SOM — Serviceable Obtainable Market | €٥٠٠ thousand | Your realistic early share |
Basis of Sizing: The total market size is based on the overall pharmacy market in Spain for 2026. The serviceable available market is estimated as a portion of community pharmacies. The serviceable obtainable market represents a small portion of the available market achievable in the early years.
Unit Economics
Measures the profitability of each sales unit/customer — the most accurate feasibility indicator:
| Unit Indicator | Value |
|---|---|
| Sales Unit | Prescription/customer |
| Avg. Price/Revenue per Unit | €١٢ |
| Customer Acquisition Cost (CAC) | €٧ |
| Customer Lifetime Value (LTV) | €٣٠٠ |
| LTV/CAC Ratio | ٤٢٫٩× (Healthy) |
| Contribution Margin | ٣٠٪ |
Competitive Analysis
The competitive landscape in Spain is characterized by a vast network of strictly regulated independent pharmacies [28]. Key competitors are other community pharmacies in the targeted geographic area. Most wholesale pharmaceutical companies are concentrated in large cooperatives [22]. The project's sustainable advantage will lie in providing exceptional customer service, offering specialized and personalized pharmaceutical advice, and providing a diverse range of products and services beyond just dispensing medications, such as skincare products, nutrition, simple medical devices, in addition to digital presence for OTC products [2, 7, 24]. Focusing on building strong relationships with the local community and doctors will also contribute to the competitive advantage.
Market Entry and Pricing Plan
The market entry and marketing plan includes multiple strategies. First, the focus will be on a strategic geographical location that meets the needs of a specific local community [2]. Second, strong relationships will be built with local doctors and healthcare centers to encourage referrals. Third, local marketing will be used through signage, opening offers, and social media. Fourth, customer loyalty programs can be offered. Fifth, emphasis will be placed on providing superior consulting services to enhance trust and loyalty. As for pricing, prescription drug prices are subject to strict government regulation in Spain [8, 10, 42]. For other products, competitive pricing will be adopted while maintaining healthy profit margins.
Capacity and Operations
The pharmacy plans to serve approximately 100-150 customers daily in the first year, with a gradual increase in occupancy to reach 200-250 customers daily by the third year, focusing on efficiency and excellent customer service.
Daily pharmacy operations include inventory management, dispensing prescription and non-prescription medications, providing pharmaceutical consultations, and customer service. Strict adherence to quality and safety standards in drug storage and handling is required. An automated inventory management system will be used to ensure product availability and track expiration dates. Employees will be regularly trained on the latest pharmaceutical practices and customer service standards. Spanish pharmacies are committed to providing high-quality health services as part of the general healthcare system [7, 32].
The technical aspects of the project require leasing or purchasing a site with a minimum area of 70 square meters, with an interior design that complies with health and safety standards and drug storage [20]. The pharmacy must be equipped with necessary equipment such as display shelves, drug refrigerators, an inventory management system, and point-of-sale terminals. Suppliers include major wholesale pharmaceutical distribution companies in Spain such as Cofares, Bidafarma, and Alliance Healthcare Spain [28]. All necessary health and industrial licenses must be obtained from the relevant Spanish government authorities [20, 25, 41].
Projected Income Statement (5 Years)
| Item \ Year | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Revenues | €٤٥٠٬٠٠٠ | €٤٧٢٬٥٠٠ | €٤٩٦٬١٢٥ | €٥٢٠٬٩٣١ | €٥٤٦٬٩٧٨ |
| Cost of Sales | (€٢٩٢٬٥٠٠) | (€٣٠٧٬١٢٥) | (€٣٢٢٬٤٨١) | (€٣٣٨٬٦٠٥) | (€٣٥٥٬٥٣٦) |
| Gross Profit | €١٥٧٬٥٠٠ | €١٦٥٬٣٧٥ | €١٧٣٬٦٤٤ | €١٨٢٬٣٢٦ | €١٩١٬٤٤٢ |
| Operating Expenses | (€١١٢٬٥٠٠) | (€١١٨٬١٢٥) | (€١٢٤٬٠٣١) | (€١٣٠٬٢٣٣) | (€١٣٦٬٧٤٤) |
| EBITDA | €٤٥٬٠٠٠ | €٤٧٬٢٥٠ | €٤٩٬٦١٣ | €٥٢٬٠٩٣ | €٥٤٬٦٩٨ |
| Tax | (€٠) | (€٠) | (€٠) | (€٣١٤) | (€٧٠٥) |
| Net Profit | €-٥٬٠٠٠ | €-٢٬٧٥٠ | €-٣٨٧ | €١٬٧٧٩ | €٣٬٩٩٣ |
| Net Margin | -١٪ | -١٪ | -٠٪ | ٠٪ | ١٪ |
Investment Cost Structure
| Item | Cost | Percentage |
|---|---|---|
| Site Renovation and Equipping | €٨٧٬٥٠٠ | ٣٥٪ |
| Initial Inventory Purchase | €١٠٠٬٠٠٠ | ٤٠٪ |
| Licenses and Legal Fees | €٢٥٬٠٠٠ | ١٠٪ |
| Pharmacy Management System and Software | €١٢٬٥٠٠ | ٥٪ |
| Opening Marketing Expenses | €١٢٬٥٠٠ | ٥٪ |
| Emergency Working Capital | €١٢٬٥٠٠ | ٥٪ |
Cash Flow and Break-even Point
| Year | Operating Cash Flow | Cumulative Cash Flow |
|---|---|---|
| Year 1 | €٤٥٬٠٠٠ | €-٢٠٥٬٠٠٠ |
| Year 2 | €٤٧٬٢٥٠ | €-١٥٧٬٧٥٠ |
| Year 3 | €٤٩٬٦١٣ | €-١٠٨٬١٣٧ |
| Year 4 | €٥١٬٧٧٩ | €-٥٦٬٣٥٨ |
| Year 5 | €٥٣٬٩٩٣ | €-٢٬٣٦٥ |
Estimated break-even point at an annual revenue of ≈ €٤٦٤٬٢٨٦ (~١٠٣٪ of first-year revenue), with a contribution margin of ٣٥٪. Cumulative cash break-even after the study horizon.
Funding Structure
| Funding Source | Percentage | Amount |
|---|---|---|
| Equity | ٦٠٪ | €١٥٠٬٠٠٠ |
| Debt Financing (٥٪ interest) | ٤٠٪ | €١٠٠٬٠٠٠ |
Sensitivity Analysis (Revenue × Operations)
The combined impact of changes in revenue and costs on Net Present Value:
| Revenue \ Operations | −10٪ | −5٪ | Base | +5٪ | +10٪ |
|---|---|---|---|---|---|
| −20٪ | €٣٢٬٤٤٧ | €-٣١٬٠٥٧ | €-١٠٠٬٥٧٩ | €-١٧٥٬٢٨٩ | €-٢٥٠٬٠٠٠ |
| −10٪ | €٦٤٬١٩٩ | €-٧٬٢٤٣ | €-٨١٬٩٠١ | €-١٦٥٬٩٥١ | €-٢٥٠٬٠٠٠ |
| Base | €٩٥٬٩٥١ | €١٦٬٥٧١ | €-٦٣٬٨٧٥ | €-١٥٦٬٦١٢ | €-٢٥٠٬٠٠٠ |
| +10٪ | €١٢٧٬٧٠٣ | €٤٠٬٣٨٥ | €-٤٧٬٠٠١ | €-١٤٧٬٢٧٣ | €-٢٥٠٬٠٠٠ |
| +20٪ | €١٥٩٬٤٥٥ | €٦٤٬١٩٩ | €-٣١٬٠٥٧ | €-١٣٧٬٩٣٤ | €-٢٥٠٬٠٠٠ |
Scenario Analysis
| Scenario | Probability | NPV | Assessment |
|---|---|---|---|
| Pessimistic | ٢٥٪ | €-١٣٧٬٩٣٤ | Unfeasible |
| Base | ٥٠٪ | €-٦٣٬٨٧٥ | Unfeasible |
| Optimistic | ٢٥٪ | €١٦٬٥٧١ | Feasible |
Expected Present Value (Weighted): €-٦٢٬٢٧٨.
Risk Analysis and Management
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| Intense competition in certain areas | Medium | Medium | Focus on excellent customer service and providing specialized services |
| Regulatory or legislative changes | Low | High | Continuous monitoring of legislation and rapid adaptation to any changes |
| Fluctuations in drug prices | Medium | Medium | Diversify inventory and negotiate with suppliers for best prices |
| Difficulty in initial customer acquisition | Medium | Medium | Strong local marketing strategy and building relationships with doctors |
| Shortage of qualified staff | Low | Medium | Offer competitive compensation packages and benefits and continuous training |
Organizational Structure and Team
The project's organizational structure requires a licensed pharmacist as owner and project manager, as Spanish law requires the pharmacy owner to be a pharmacist [2, 20]. Additionally, the team will include pharmacy assistants and technicians to provide support in sales, inventory management, and customer service [2]. Working in a pharmacy requires specific academic qualifications and professional licenses in Spain [21].
Legal and Regulatory Aspects
Pharmacies in Spain are subject to strict regulation at both national and regional levels [2]. Licenses require a university degree in pharmacy and registration with the Official College of Pharmacists (Colegio Oficial de Farmacéuticos) in the region [2, 21]. They are also subject to location and density requirements to ensure fair distribution of pharmaceutical services [2]. Prescription drugs cannot be sold online [2]. Compliance with all health regulations and legislation related to drug sales, including government-set pricing regulations, is mandatory [10, 42].
Expansion and Sustainability Plan
Future expansion for the project could include opening additional pharmacies in other high-demand areas, or specializing in certain pharmaceutical services such as clinical pharmacy or nutrition [32]. Partnerships with healthcare centers or specialized clinics can also be explored. To ensure sustainability, the focus must be on innovation in services, such as developing a digital platform for health advice or selling OTC products online (while adhering to regulations) [2, 7].
Environmental, Social, and Governance (ESG) Impact
The project will focus on environmentally sustainable practices through proper pharmaceutical waste management, reducing in-store energy consumption, and encouraging the use of eco-friendly products. Socially, the pharmacy will contribute to community health and well-being by providing accessible and reliable healthcare services [32]. Good governance standards will be adhered to through transparency, accountability, and compliance with all regulations and laws.
Conclusions and Recommendations
The pharmacy project in Spain represents a promising investment opportunity in a vital and stable sector. Thanks to the increasing demand for medicines and healthcare and supportive government regulation, the pharmacy can achieve sustainable profits. Success requires a strong commitment to customer service, regulatory compliance, and adaptability to market changes. The recommendation is to proceed with the project with a focus on meticulous implementation of the operational and marketing plan.
Frequently Asked Questions
How much does it cost to open a pharmacy in Spain?
The proposed initial capital for a pharmacy project in Spain can range around €250,000, including renovation, initial inventory, and licenses.
How much profit does a pharmacy make in Spain?
The average revenue for a pharmacy in its first year can reach approximately €450,000, with a contribution margin of 30%.
What are the licenses required to open a pharmacy in Spain?
Licenses require a university degree in pharmacy, registration with the Official College of Pharmacists in the region, in addition to health and industrial licenses from government authorities [2, 20, 21].
Is a pharmacy project profitable in Spain?
Yes, a pharmacy project is considered profitable in Spain due to the continuous demand for medicines and healthcare, regulation that limits unregulated competition, and stable growth rates in the sector [3, 5, 6].
What is the average price of a prescription in Spain?
The average price of a single prescription in Spain is approximately €11.50 [8].
Sources and Disclaimer
- IBISWorld: Chemists & Pharmacies in Spain Industry Analysis, 2026 [3]
- Grand View Research: Spain pharmaceutical market highlights [5]
- IMARC Group: Spain Pharmaceutical Market Overview [6]
- Estatefy: Pharmacies in Spain: Everything You Need to Know [2]
- CostaLuz Lawyers: Spain Corporate Tax Rate 2026 [4]
- Reddit: How Much Do Medications Cost in Spain? A Guide for Expats [10]
Disclaimer: This is an indicative study providing financial analysis according to accepted industry standards; verify figures locally according to your project's reality before any investment decision.
